Trial intelligence / Profile preview

Effect of two doses of ketorolac in the treatment of acute renal colic pain

IRCT20201018049062N1Phase 2Completed

Sponsor
Zahedan University of Medical Sciences
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of ketorolac in Renal colic (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Pain relief efficacy. Started Dec 2020; status: completed.

02

Drugs

ketorolac
03

Conditions

Renal colic

Beyond the preview

Go deeper on IRCT20201018049062N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201018049062N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call